Dustin Hoffman, MD
Orthopaedic Surgery · Wilmington, NCNPI 1841528502
Payments from drug & device makers
Across 143 payments — averaging $299.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$37K
- Zimmer Biomet$2K
- Total Joint Orthopedics, Inc.$1K
- Stryker$872
- Johnson & Johnson$738
- Medacta USA, Inc.$573
- plus $334 from 9 others
What the payments were for
- Consulting fees$25,39759%
- Travel & lodging$10,16224%
- Food & beverage$7,33117%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 69 | $37,116 |
| Zimmer Biomet | 18 | $2,155 |
| Total Joint Orthopedics, Inc. | 10 | $1,102 |
| Stryker | 13 | $872 |
| Johnson & Johnson | 16 | $738 |
| Medacta USA, Inc. | 5 | $573 |
| Think Surgical, Inc. | 3 | $163 |
| Medical Device Business Services, Inc. | 1 | $45 |
| Avanos Medical | 2 | $29 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Heron Therapeutics, Inc. | 1 | $19 |
| ERMI LLC | 1 | $17 |
| Pacira Therapeutics, Inc. | 1 | $15 |
| KCI USA, Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$32,655
- REAL INTELLIGENCE$24,946
- K-15 PORK$19,950
- Legion$10,500
- R3 ACETABULAR$6,124
- JOURNEY$2,822
- RI.HIP NAVIGATION$1,654
- Navio Surgical System$1,175
- Journey II XR$1,028
- Avenir$1,015
- PICO$924
- POLARSTEM$784
- Tandem$644
- JII Unicondylar Knee System$530
- REDAPT Revision Hip System$498
- MAKO$488
- AMISTEM$477
- Journey II BCS$168
- Persona$122
- TFN-Advance$108
How this compares
$42,890 in reported general payments places this provider in the 80th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 666 | $1,924 |
| Mupirocin | 222 | $1,653 |
| Cefdinir | 101 | $1,406 |
| Celecoxib | 29 | $971 |
| Methylprednisolone | 172 | $870 |
| Oxycodone Hcl | 162 | $744 |
| Gabapentin | 88 | $642 |
| Dexamethasone | 43 | $306 |
| Ondansetron OdtOndansetron | 36 | $251 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $138 |
| Amoxicillin | 73 | $99 |
| Pantoprazole Sodium | 14 | $85 |
| Tramadol Hcl | 31 | $41 |
| Clindamycin Hcl | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Wilmington
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$6.2M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$5.2M
- Mark EasleyDurham$4.2M
- Carroll JonesCharlotte$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.